G. Sévigny

发表

In Vitro Antiviral Activity and Cross-Resistance Proﬁle of PL-100, a Novel Protease Inhibitor of Human Immunodeﬁciency Virus Type 1 (cid:1)

M. Wainberg, J. Schapiro, N. Parkin, 2007 .

Structure of the gene coding for the mouse TRiC-P5 subunit of the cytosolic chaperonin TRiC.

N. Lemieux, V. Bibor-Hardy, A. Steyaert, 1996, Genomics.

Assignment of the human homologue of the mTRiC-P5 gene (TRIC5) to band 1q23 by fluorescence in situ hybridization.

N. Lemieux, E. Joly, V. Bibor-Hardy, 1994, Genomics.

Lysine sulfonamides as novel HIV-protease inhibitors: Nε-Acyl aromatic α-amino acids

Jinzi J. Wu, B. Stranix, J. Yelle, 2006 .

1,2,5,6-tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitors.

Abderrahim Bouzide, Gilles Sauvé, Guy Sévigny, 2003, Bioorganic & medicinal chemistry letters.

The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo.

R. Ménard, D. Tessier, E. Chevet, 2000, Glycobiology.

Lysine sulfonamides as novel HIV-protease inhibitors: Nε-disubstituted ureas

A. Côté, B. Stranix, J. Yelle, 2004 .

Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor.

C. Petropoulos, B. Conway, Y. Lie, 2006, Antiviral research.

cDNA encoding a novel TCP1-related protein.

I. Todorov, E. Joly, V. Bibor-Hardy, 1994, Biochimica et biophysica acta.

In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Novel Protease Inhibitor of Human Immunodeficiency Virus Type 1

M. Wainberg, J. Schapiro, N. Parkin, 2007, Antimicrobial Agents and Chemotherapy.

Lysine sulfonamides as novel HIV-Protease inhibitors: optimization of the Nε-acyl-phenyl spacer

A. Côté, B. Stranix, J. Yelle, 2003 .

Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacer.

A. Côté, B. Stranix, J. Yelle, 2003, Bioorganic & medicinal chemistry letters.